
1. trends parasitol. 2013 oct;29(10):497-504. doi: 10.1016/j.pt.2013.07.008. epub
2013 aug 12.

monitoring antifolate resistance intermittent preventive therapy malaria.

venkatesan m(1), alifrangis m, roper c, plowe cv.

author information: 
(1)howard hughes medical institute/center vaccine development, university 
maryland school medicine, 685 west baltimore street, hsf1-480, baltimore, md
21201, usa; worldwide antimalarial resistance network (wwarn) molecular
module(*).

mutations plasmodium falciparum genes pfdhfr pfdhps rendered
sulfadoxine-pyrimethamine (sp) ineffective malaria treatment regions 
of world. yet, sp efficacious intermittent preventive therapy in
pregnant women (iptp) infants (ipti) seasonal malaria control in
children (smc). sp-iptp widely implemented sub-saharan africa.
sp-ipti recommended prevalence sp-resistant malaria parasites 
low, whereas smc recommended areas intense seasonal malaria
transmission. continuing success interventions depends largely on
the prevalence pfdhfr pfdhps resistance mutations target
population. review relationship resistance mutations and
sp-ipt within target populations context monitoring informing
implementation intervention.

copyright Â© 2013 elsevier ltd. rights reserved.

doi: 10.1016/j.pt.2013.07.008 
pmcid: pmc3810209
pmid: 23948432  [indexed medline]

